Skip to main content
Important update on COVID-19

Important update on COVID-19

Some changes to access in response to COVID-19 precautions.

COVID-19 update

ANSTO is committed to the health and wellbeing of our people, partners, customers and communities. In response to the COVID-19 we have made some changes to our operations. In response to the COVID-19 we have made some changes to our operations.

ANSTO’s operations are unique within Australia. We operate Australia’s only nuclear reactor and also produce and distribute nuclear medicines used to assist with the diagnosis of heart disease, skeletal injuries and also the diagnosis and treatment of a range of cancers, for Australians.

The majority of ANSTO staff across all three of our campuses are now working remotely. These adjustments are being designed to support the Australian Government’s measures to slow and help surpress the spread of the virus within the community and also protect ANSTO’s critical role in delivering nuclear medicines for Australians. 

At this point in time, we have made modifications which will impact the scientific user community and public engagement activities as outlined below.

User services for research and industry

user services covid19

To all ANSTO users, visitors and colleagues, 

Regrettably, ANSTO anticipates that the current suspension of user program experiments could be in place for at least two and up to four months. If circumstance allow, we will recommence operations sooner. We will keep you informed of our actions by email and on our website as further national and state COVID-19 measures unfold.

Facilities at Lucas Heights, Camperdown and Clayton intend to reschedule all cancelled experiments from the current round once normal operations are resumed. Arrangements regarding how this will be done, as well the management of new proposals for the 2020-2 round will depend on and be determined by the recommencement of normal operations.

Please continue to contact NSW User Office (Lucas Heights and Camperdown) or VIC User Office (Clayton) if you have any questions.

Tours and public events

OPAL tours and events covid19 update

All public tours and school group tours are now on hold until further notice. Schools and visitors who have booked a tour are being contacted by the ANSTO Discovery Centre.

The Easter school holiday workshops will not proceed, however we plan to resume our school holiday workshop program later in the year.

nandin Innovation Centre will continue to operate as usual for our members.

Products and services

Covid19 products and services v2


Laboratory and pilot based work will be reduced for the time being. We’ll focus on delivering all work that has been completed to date and will discuss with customers how best to deliver remaining work as the situation improves.


At this time, we have deferred all on site based Synroc activities. The Synroc team will continue to operate remotely to deliver on stakeholder requirements and will be in touch with clients directly should there be any relevant changes. 

Silicon Irradiation

Business operations continue as usual for the time being.

Radiation Services

  • Instrument calibrations are operating in a limited capacity only, with only essential instruments able to be calibrated. 
  • Training course delivery is temporarily suspended. All persons enrolled in a course will be contacted directly if their course has been suspended. 
  • Radiation Consultancy work that has been completed to date will be finalised and we will discuss with you how best to deliver remaining work and options for that as the situation improves. 

If you require more information or assistance please contact our team via or call +61 2 9717 3251.

Health Products

covid-19 update health

As outlined above, we will work to maintain the supply of critical nuclear medicines for all Australians during this period.

We are considering the impact on local and overseas supply and are providing customer updates directly as we gain further information. If you have any questions, please contact our customer service team on 1800 251 572. 

Thank you for your support, we look forward to resuming normal operations at the appropriate time.